Sino Biopharmaceutical Limited (HKEX: 1177) offers a trailing and forward dividend yield hovering around 1.9% to 2.1%, reflecting its commitment to returning regular capital to shareholders. The corporation maintains a structured semi-annual dividend distribution schedule, supported by a comfortable earnings payout ratio and healthy operational cash flows. This consistent dividend history appeals to income-oriented investors seeking exposure to the pharmaceutical sector alongside potential long-term capital appreciation.